Transparency Market Research

Protein Engineering Market to Gain from Emphasis on Development of Protein-Based Drugs

Transparency Market Research Report Added "Protein Engineering Market" to its database.


Albany, NY -- (SBWIRE) -- 02/09/2016 -- Protein engineering – the technique of manipulating protein structures to achieve desired properties or the synthesis of proteins to create complex structures – is being widely applied across industry verticals. As a result, the global protein engineering market is expected to grow remarkably over the next few years. A report by Transparency Market Research studies the global protein engineering market to offer growth forecasts as well as a qualitative analysis of the market. The report is titled, 'Protein Engineering Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2015–2023.'

The use protein-based drugs, which are preferred for their high specificity, is expected to stimulate the demand for protein engineering. An increase in the number of amino acids and engineered proteins produced across the world will also fuel the global protein engineering market, the report states. The greater the prevalence of chronic diseases and lifestyle-related disorders, the higher will be the demand for effective therapies. This trend will have a bearing on the trajectory of the global protein engineering market, say TMR analysts.

Request For Sample:

By protein type, the market has been segmented into: monoclonal antibodies, insulin, vaccines, erythropoietin, coagulation factors, growth hormones, interferon, and others. Likewise, by technology, the market is segmented into: irrational protein design and rational protein design. From the standpoint of end users, the market is composed of: academic research institutes, pharmaceutical industries, and contract research organizations.

Governments' support for research and development activities is projected to have a positive impact on the state of protein engineering in both advanced and developing countries. With an emphasis on reducing the burden of diseases on national economies, programs centered on developing efficacious drugs have received a push. The protein engineering market will be a beneficiary of such developments.

The report states that North America contributes significantly to the global protein engineering market, given the high concentration of academic and commercial research establishments located in the region. Governments of the U.S., Canada, and Brazil have been highly supportive of advancements in protein engineering, creating a favorable regulatory environment for companies in the North American market. Europe follows close on the heels of North America owing to similar growth factors. Asia Pacific is beginning to show much promise as an investment destination for companies in the protein engineering market because of the presence of numerous contract research organizations (CROs) and the sheer number of people suffering from chronic diseases that can be treated with protein-based therapies. This catapults Asia Pacific to the leading position as far as the rate of growth in the protein engineering market is concerned.

The leading players that have been profiled in the report on the protein engineering market are: Bio-Rad Laboratories, Inc., Novartis AG, GlaxoSmithKline Inc., Thermo Fisher Scientific, Eli Lilly and Company, Genentech, Inc., and others.

The market of protein engineering can be segmented into:

By Protein Type
Monoclonal Antibodies
Growth Hormones
Coagulation Factors

By Technology
Rational Protein Design
Irrational Protein Design

By End Users
Pharmaceutical Industries
Contract Research Organizations (CROs)
Academic Research Institutes

Contact us
Mr. Sudip S
Transparency Market Research
90 State Street,
Suite 700,
NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free 866-552-3453